Isomorphic Labs Raises $2.1 Billion as AI Drug Discovery Reaches Critical Mass

The biotechnology landscape underwent a radical transformation with the announcement that Isomorphic Labs, the health-focused DeepMind spinout, has raised $2.1 billion. This funding round is not merely a record-breaking figure for the sector, it represents a major institutional bet on the ability of artificial intelligence to drastically reduce the time and cost of new drug discovery. Traditionally, bringing a new drug to market requires over a decade and billions of dollars…